An updated assessment of hepatitis delta prevalence among adults in Canada: A meta‐analysis
Journal of Viral Hepatitis · 2024
DOI: 10.1111/jvh.13939 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Viral Hepatitis, 2024. Verfasst von Robert J Wong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California, USA. Hauptthemen laut MEDLINE: Hepatitis D, Hepatitis Delta Virus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Foreign‐born (FB) persons represent a large proportion of adults with chronic hepatitis B (CHB) in Canada due to higher prevalence rates in countries of birth for FB persons. Suboptimal awareness and low rates of hepatitis delta virus (HDV) testing contribute to underdiagnosis and gaps in accurate estimates of Canada HDV prevalence. We aim to provide an assessment of CHB and HDV prevalence in Canada using a comprehensive literature review and meta‐analysis. A comprehensive literature review of articles reporting HBsAg seroprevalence and anti‐HDV prevalence was conducted to calculate country‐specific rates and pooled prevalence of CHB and HDV using meta‐analyses. Country‐specific CHB and HDV rate estimates were combined with number of FB persons in Canada in 2021 from Statistics Canada to estimate total numbers of FB with CHB and HDV, respectively. These estimates were combined with estimates of Canada‐born persons with CHB and HDV to yield the total number of persons with CHB and HDV. In 2021, we estimated 0.550 million (M) (95% CI 0.488–0.615) persons with CHB; 0.344 M (95% CI 0.288–0.401) were FB and 0.206 M (95% CI: 0.200–0.214) were Canada‐born. The weighted average HDV prevalence among FB persons in Canada was 5.19% (17,848 [95% CI 9611–26,052] persons), among whom 50% emigrated from Asia and 31% from Africa. When combined with estimates of Canada‐born persons with HDV, we estimate 35,059 (95% CI: 18,744–52,083) persons with HDV in Canada. In conclusion, we estimate 0.550 M and 35,059 persons living with CHB and HDV, respectively, in Canada in 2021.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California, USA.
- Gastroenterology Section Veterans Affairs Palo Alto Healthcare System, Palo Alto, California, USA.
- Toronto Centre for Liver Disease, University Health Network, Toronto, Ontario, Canada.
- S Wong Consulting, LLC, Mountain View, California, USA.
- Department of Medicine, Epidemiology and Biostatistics, University of California, San Francisco, California, USA.
- Department of Medicine, Aga Khan University, Karachi, Pakistan.
ORCID-Profile: Robert J Wong, Cihan Yurdaydin
Zitieren
APA
Wong, R. J., Hirode, G., Feld, J., Wong, S. S., Brosgart, C., Glenn, J., Hamid, S., Cohen, C., Zovich, B., Ward, J., Wedemeyer, H., Yurdaydin, C., & Gish, R. (2024). An updated assessment of hepatitis delta prevalence among adults in Canada: A meta‐analysis. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.13939
Vancouver
Wong RJ, Hirode G, Feld J, Wong SS, Brosgart C, Glenn J, et al. An updated assessment of hepatitis delta prevalence among adults in Canada: A meta‐analysis. Journal of Viral Hepatitis. 2024. doi:10.1111/jvh.13939
BibTeX
@article{Wong2024,
author = {Wong, Robert J and Hirode, Grishma and Feld, Jordan and Wong, Steven S and Brosgart, Carol and Glenn, Jeffrey and Hamid, Saeed and Cohen, Chari and Zovich, Beatrice and Ward, John and Wedemeyer, Heiner and Yurdaydin, Cihan and Gish, Robert},
title = {An updated assessment of hepatitis delta prevalence among adults in Canada: A meta‐analysis},
journal = {Journal of Viral Hepatitis},
year = {2024},
doi = {10.1111/jvh.13939}
}
EUVIMED